Mat Lucas
Dentistry
Biocare Diagnostics Ltd.
Sweden
Biography
Dr. Lucas has been exposed to diverse therapy areas including anti-infectives, pain, cardiovascular, immunology, and neuroscience that has given him a broad understanding of the various challenges in drug discovery. Prior to joining Yumanity, Dr. Lucas was Director of Medicinal Chemistry and member of the Discovery and Non-Clinical Development Research Leadership Team at Cubist Pharmaceuticals until it was acquired by Merck Research Laboratories. Before joining Cubist, Dr. Lucas worked at Roche Pharmaceuticals as sites in Palo Alto, Basel and Nutley.
Research Interest
Dentistry
